1/239
Looks like no tags are added yet.
CD location and symptoms
Transmural Inflammation of any part of GIT but usually near ileocecal valve (often discontinuous), can lead to fibrosis, strictures/fistula
Is WATERY DIARRHEA (Blood rare), RLQ abedominal pain, low grade fever, malabsorption, weight loss
UC location and symptoms
Mucosal inflammation start at distal rectum and up into colon
Symptoms: BLOODY diarrhea, rectal urgency, feeling of incomplete defecation, weight loss
3 parts of patho for CD/UC (what specific for CD vs UC)?
Antigen exposure: rip epithelial barrier, access of bacterial antigens to APCs (dendritic cells)
T cell activated: APC present antigen to CD4+ and secrete cytokines:
Dendritic cell turn Th10 Cell into Th1 cells (seen more in Crohn's disease): TH1 cells then release IFNy and TNFa to activate macrophage
TH2, reg, and 17 more so UC
TH2 cells recruit lymphocytes and onocytes, or leukocytes, requires integrin adhesion molecule

Mesalamine based therapy aminosalicylates MOA, location where, and effectiveness for UC vs CD?
Metabolized in distal gut to form AZO BOND LINKS To bccteria ONLY
5-ASA is a metabolite that is reponsible for anti inflammation, but not thorugh COX inhibition but rather directly inhibit IL and TNF (exact MOA unknown)
Location: Acts at varying sites in GIT (cna be suppository, enema, delayed release, pH coating)
Effectiveness: More effective in UC than CD (UC for mild to moderate, CD has modest benefit and not great for remission)
Amino salicylates PK? (metab special how?)
Sulfasalazine: metabolized to 5-ASA and sulfapyridine:
Sulfa pyridine is highly lipid soluble and goes through extensive liver metab
Acetylation phenotype DETERMINES ADES for SULFAPYRIDINE
Corticosteroids MOA and use
Anti inflammation
used for acute attacks and pts with moderate to severe disease
40% are responsive, 30-40% have partial repsonse/become dependent and 15-20 just don't respond
6 mercaptopurine prodrug form, MOA, issues/Metab special how?
Purine analog metab that impairs PURINE bio synthesis and inhibit cell proliferation
Can cause pancreatitis, fever, BONE MARROW SUPPRESSION
Polymorphism in TPMT have increased risk of bone marrow suppression
Azathioprine is PRODRUG FROM
6 MPT goes through 3 metabs (Xo -> 6 hioturic, TMPT to 6mmp and HGRT to 6 thioguanine), but main one is TPMT into 6 methyl MPT (however if have low TPMT then more danger)
Giving IM /SC for induction and remission of Crohn's. is unaltered in urine, and quick t1/2.
Immunomodulator for those are have severe IBD and are steroid resistant/dependent
Methotrexate MOA, use in only what? Dosing how?
Folate acid analogue that inhibits DHFR to block DNA synthesis and cause cell death, inhibit T cell activation
USE ONLY IN CROHN'S
IM/SC Dosing
Biologics MOA, use for what, inflixi vs adali, vs certoli?
Binds and nuetralize soluble and membrane bound TNFa, blocks TH1 response (used only for Crohn's)
Inflixi: chimeric mAB that is IV
Adalimumab: human Mab against TNFa that is SC
Certolizumab pegol: humanized peglyated Fab against TNFa that is SC
Janus kinase inhibitors description
PO small moleucle drugs that inhibit transcription of inflammation cytokines, is variably selective (tofacitinib treats UC inhibits JAK1 and JAK3, updactinib treats both UC and Crohns, target Jak)
Only use if failed TNF
Ustekinumab and Risankizumab MOAs
Uste: MAB that targets subunit to IL12 and Il23 to prevent activatino of receptors on lymphocytes
Risan: il23 antag
Vedkolizumab MOA
Used for CD, inhibits leukocyte adhesion and migratino by targeting a4 integrin
Sphingosine-1 phosphate receptor modulators (2) and MOA
Etra and ozanimod are oral S1p recepctor modulators: (S1p for immune cell trafficiking, affect immune cell migration from lymphoid organs to circulatory system then)
IBD description
DiChronic disease with relapsing inflammation amnd ulceratino of intretsine
UC and CD are both multi non instetinal comorbidities associated
Type 1 peripheral arthritis, oral ulcers, inflammatory skin and oculr lesions
Primary sclerosing cholangitis
Osteroporoiss, ankylsogin sponydlyitis
UC classic presentation, how diagnose, and begins where?
BLOODY DIARRHEA, tenesmus, rectal urgency (Can have unexplained weight loss and growth retardation in children)
Diagnose through colonoscopy or sigmoidoscopy (include CBC, CRP, fecal cal protein stool culture CDiff assay)
Always starts in rectuma nd up into colon
5 types of UC and how far up
Proctitis (only rectum)
Proctosigmoiditis (litter higher)
Above is 46% of patients
DISTAL COLITIS/left sided: full left side of colon: 17% of patients
Extensive colitis (next semgnet) and pancolitis (FULL): 37% of patients

Mild vs moderate vs severe UC how many poops abnormal labs? symptoms?
Mild: < 4 stools/day with minimal blood, Normal HR< CRP and ESR, MILD ab pain and tenesmus
Moderate: 4-6 BLOODy stools/day: normalt o minimally elevated HR, CRP and ESR
Mild anemia (Hgb>10), mild-moderate pain tenesmus, NO WEIGHT LOSS
Severe:>6 BLOODY stools/day, >37.8 Celsius, >90bpm HR, Hgb
Low risk for long term complications how for UC?? (Diagnosis age, disease, what kind of coliits, normal what? no cuts how? No extra what?)
Diagnose at >40 years
Mild-moderate disease
Proctitis, proctosigmoiditis, or LEFT sided colitis
NO EXTRA INTESTINAL MANIFESTATION
No fever/weight loss, normal labs, no deep ulcerations
High risk for long term complicatino for UC how? (Age, disease, what kind, drug requriement? hx? labs bad how and infectinos of what)
Age < 40 years at diagnose
Moderate-dsevere disease
EXTENSIVE COLITIS
Glucocorticoid requried for remission
Hx of hospitalization for UC
Deep ulcerations, elevated CRp/ESR
CDiff or CMV infection
Crohn's Disease ileoclitis vs perianal vs colitis vs other presentations for each kind?
Ileocolitis (only ascending colon and ileum), is 50% of patents, ab crampin on lower RIGHT side and Watery diarrhea+weight loss
perianal (25%): Bloody diarrhea+PERIANAL FISTULAS
Colitis (20%): bloody diarrhea, perianal fistulas and abscesses
Other: low grade fever, malabsorption (iron, zinc, folate, b12)
Complications ofr Crohn's idsease and how diagnose?? When do MRI?
Stricture, obstructiona nd fistulas, seen
Diagnose through CT/MRI/US (MRI FOR PATIENTS
CD Mild vs moderate-severe vs severe-fulminant (symptoms, bowel, deficiencies, signs of what? How respond to drugs?)
mild: low risk of progression and surgery: no systemic signs of toxic, normal/slight CRP or FC elevation, limited bowel invovlement, no perianal, no severe lesion, strictures or fistulas
Moderate-severe: Refractory to 1st line treatments for mild-moderate CD, fever/wegith loss, ab pain, N/V
Elevated CRP/FC, anemia or vitamin/mineral def, larger ulcers, bowel inveolement, fistulas, perianal inovleemt
Severe: Continued symptoms ON CORTICOSTOIERDS /biologics
HIgh fever, rebound tenderness, severe mucosal disease, signs of intestinal obstruction/abscess
Risk factors for long term CD complication? (Age use, disease level, use, hx, response to cortico?
Diagnose at
Pre biologic vs biologic era drugs 3+2
Pre: 5-ASA (NOT EFFECTIVE FOR CD), corticosteroids (not good for maintaining remission), immune modulators for not weaning of cortico
Bio: mabs (TnA, anti integrin, anti IL), and small molecule biologics (JAKs, S1p)
Mesalamine MOA, ADEs, dosing?
ADes: Leakage with enema, localized bloating/pain
Have an enema and suppostiory form
FOR UC ONLY for left side disease only really
Oral ASA overall ADEs and bad in what way?
Slower to induce remission and more ADE than rectal 5 asa
ADE: headache, dyspepsia, rash diarhea
Azo bonded prodrugs 2, and caveat for olsalazine?
Olsalazine is 2 azo bonded molecules, strong, so diarrhea is DOSE RELATED AND TREATMENT LIMITING
Also have balsalazide (Bonded to inert carrier)
Delayed release 5 asa oral special how? (Asacol, pentasa, lialda)
Asacol: target terminal ielum and colon cause enteric coated
Pentasa capsules: Microspheres inside semipermeable membrane, retains water in intestine, and becomes slow release gel, so target duodenum, jejunum, ileum and colon
Lialda: enteric coated with 5 asa inside lipophilic matrix around hydrophilic matrox, slow release gel target only ileu and colon
SulfaSALAzine MOA, absorbed how, bad in what way?? DDIs and CIs?
5 azo bonded to sulfa pyridine, sulfapyridine absorbed systemically once 5 asa is released BAD
ADEs: Dose related: n/V, anorexia, diarrhea, folate malabsorption
Non dose related: rash, anemia, decreased sperm, BONE MARROW SUPPRESSION, hepatitis
Dis: ABX, decreased absopriton of folic acid/ferous sulfate, displace highly protein bounddrugs by sulfapyridine
CI with SULFA ABX ALLERGY
Corticstoeirds treatment limiting ADEs, what is preferred agent, and used how? WHAT IS LENGTH LIMIT
Fluid retention, moon face, hyperlipidemia, caracacts, osteo, muscle pain, increased infection, glucose intolerance
Budeosnide > prednisone or prednisolone cause more 1st pass so less systemic exposure
Compared to prednisone: less moon face, muscle pain and AEs
Cortico good for INDUCING remission BUT NOT MAINTAINING
used to control flares as bridging therapy until immunodmoulator work
SHOULDN'T USE > 8weeks for boht oral and rectal
immune modulators description
Steroid sparing, can maintain remission during cortico wean: needs 3-6 months of chronic dosing to become effective doe (so not good for inducing remission)
Can stop cortico after, but continue modulator for life
Indicated to decrease immunogeneicity with anti TNF a MAbs
Have AZT, 6MP, MTX
AZT or 6MP ADEs (non dose vs dose related), dosing TLDR< and test what for 6mp?
Non dose: PANCREATITIS< rash, n/v
Dose: bone marrow suppression, hepatitis
increased cancer risk
Chekc CBC q 2 weeks during induction, q 3 months during maintenace
TPMT testing with azt or 6mp: Poor metabolizers have risk of fatal myelosuppression
Some are rapid metabolizers meaning they can have therapeutic failure
MTX vs 6MP aDEs and dosing how monitor?
Works faster and less cancer than the other two
ADEs: Allergic (Interstitial pneumonia), leukopenia, hepatic fibrosis
SO monitor chest xray, CBC and liver functiont est
anti TNFa agents/Mabs class warnings
Incresed risk of tuberculosis, infections, cancer risk...? (Controversial)
lupus like syndrome
New onset of CNS disease or congestive heart failure
Reactive HBV
Infliximab description, can add what, ADEs (1 big), formulations?
Chimeric Mab (increased risk of infusion reactiona nd decreased efficacy if have immungenicity), can add immune modulators to decrease antibody formation
ADEs: Acute infusion reaction, delayed infusion reaction, and rare bone marrow suppress and severe liver tox
Give q 8 weeks
have IV and SQ
Certolizumab description, ADEs eh, dosing?
Pegylated HUMANIZED mab
ADEs; Upper respiratory infections, fever, HTN, fatigue
0, 2, 4 weeks for induction and then q month SQ
SQ so no infusion reactions
Adalimumab description ADes, dosing?
Human Mab
sinusitis and naso oof common
0, 2 week and then q 2 week to maintain
LOTS OF BIOSIMILARS
IS SQ
Golimumab Description ADEs, dosing?
ADes; upper respiratory oofs, increased liver enzymes, constipation, dizziness
Week 0, q 2 weeks then q 4 weeks for maintenance
Have SQ and IV (iv not for UC doe)
Vedolizumab moa, indications? ADEs (Good how?)
Integrin inhibitor (target a4b6 integrin in gut, so no inflammation can stick)
Indications: moderate-severe active UC/CD
ADes: Upper respiratory oof, fatigue, headache, etc. NO INCREASED CANCER RISK THOUGH
SQ
026, and then q 8 maintain
Ustekinumab MOA, indications, ADEs (gotta test what)? dosing?
Bind Human anti il2 and il23 human MAB
For moderate to severe CD patients who failed immunoimodulator/corticostoierds but not TNF blocker,s or in those who failed 1+ TNF blockers
ADes: reactivation of fungal infections, like latent TB (GOTTA TEST AT BASELINE)
Increased cancer risk
reversilbe posterior leukoencephalopathy syndrome
Risankizumab MOA, ADEs, precautions (imp) dosing? Use?
SElective anti IL 23 Mab
ADE: infection, liver tox, ab pain
Precautions: HYPERSENSITIVITY, ACTIVE TB
ONLY FOR MODERATE TO SEVERE CD, NOT UC
Mirikinzumab MOA, indications, ADEs, dangers?
SElective anti IL 23 Mab
ADE: infection, liver tox, ab pain
Precautions: HYPERSENSITIVITY, ACTIVE TB
Used for moderate- severe active UC OR CD
So very similar to risan but diff for indications
Guselkumab MOA, indication? Dangers? (2 important, special risks and avoid what), dosing?
Selective il23 human IMMUNOGLOIBULIN lambda mab
For severe active UC /CD
ADEs: Most common, upper resp infections, headache, fever, rash, arthrlagia
Precautions: HYPERSENSITIVITY< INCREASED INFECTION RISK, TB REACTIVATION< LIVER TOX
AVOID LIVE VACCINES
Selective JAK inhibitors Class AEs/BBW how, and DDIs?
BBW for:
Serious infections, lymphoma/tumors, increased risk of CV death, MI, stroke
Increased risk of DVT PE and embolism in those with 1 risk factor
Hyperlipidemia, acne, etc.
DDi with cyp3a4
Tofacitinib indication, dosing...? What not use with?
Is a JAK inhibitor
For moderate to severe active UC in adults who failed at least 1 anti TNF a agent
DOsing eh, but is ORAL NICE
SHOULDN'T USE WITH OTHER JAKI, bioligocs, or immunosuppressants
Upadacitinib indication, warning?
Is a JAK inhibitor
For moderate to severe active UC in adults who failed at least 1 anti TNF a agent
DOsing eh, but is ORAL NICE
SHOULDN'T USE WITH OTHER JAKI, bioligocs, or immunosuppressants
S1p Modulators indication (SPECIAL), DDis? Cis?
For adutls with moderate to severe active UC BUT NOT CD
DDis with CYp3a4
CIs: MI, heart stuff, AV block. Any heart sisue basically
Ozanimod and etrasimod ADEs
Ozaimod: common: upper respi, increased LFTs, headache
Rare: progressive multofical leukencoephloapthy, AV conduction delays, HTN
Etrasimod: Common: Headache, increased LFT< arthralgias,
Less common: HTN, UTI, herpes, hypercholesteremia, skin rash
Rare, (Same as ozani)
BOTH ARE PO, but ozani has an induction phase
How treat proctitis/eft sided UC (induction) (2 agents, and 2 week vs 2-4 weeks)
Is low risk/mild moderate active UC
Induction is rectal mesalamine qhs (oral less effective but ppl nonadherent to rectal)
if no improvement at 2 weeks, increase to rectal BID, or add cortisone suppositories QD and reduce mesalamine back to QHS
If no improve at 2-4 weeks: add oral meslamine or add oral budesonide MMX ore prednisone
How treat proctitis/eft sided UC (Maintenance)
Is low risk/mild moderate active UC
CAN'T USE CORTICOSTEROID FOR MAINTENACE
Preferred treatment: rectal mesalamine QHS and if oral mesalamine was used for induction, then only do oral mesalamine
Total 8 week corticosteroid course possible, with WEAN INCLUDED
Extensive UC (high risk/mild moderate active) Induction how? (4 things for alts) (thing stronger)
Standard dose oral mesalamine+rectal mesalamine
Is no improve at 2-4, then do oral mesal+recal corticstoierd, or add budesonide MMX (taper)
Or, can replace budeosnide with oral prednisone, and then taper
Maintenance of extensive UC how? 2 Add what thing to normal?
If oral mesalamine remission was achieved, stop rectal mesalamine and cont oral mesalamine at same dose
Steroid dependence: Can't wean corticosteroid without relapse, so start long term biologic
moderate-seevere active UC induction how? (2 for main (a dn alts?), and what do for relapse? test what?)
inflix trough level, adali and cetro?
If no antiboides, sub therape, no and therape, neutralizing and sub, neutralizing and thera?
First option: Anti TNF MAB+Immodulator (AZT preferred)
1-8 week response, can add oral prednisone for symptoms
MTX use if bad response to thiopurines
Cause use vedolizumab isntead of anti TNF for those with high risk of cancer
Ustekinumab preferred in patients unresponsive to AZT before
If have non responder/relapse test for: anti MAB antibodies, trough levels
Inflix:>5, adali>7.5, cetro>20
If no neutrlizing antibodies and sub therpaeutic trough:increase anti tnf dose
If have no antibodies and therpaueitc trough: change to alternate biologic drug class
If neutralizing antibodies and sub trough: low antibody level just increase dose,, if high change class
If nuetralizing and therapeutic trough: change to alternate class
Treatment of moderate to severe ACTIVE UC (top down therapy?) What agents high and low??? FOr treatment naive? Notes on Vedo and anti IL and Jaks?
Part of top down therapy (Early use of biologics/immune modulators)
Treatment naive: Choose high or intermediate efficacy agent:
high: INflixmab, vedolizumab, ozani or etrasimod, risaknizumab, guseklumab
interemdiate: golimjum, usetku,mirkizu
Low: ADALI SO DON'T USE (requries longer duration for response)
Vedolizumab and anti IL have LOWER INFECTION RISK THAN ANTI TNF MABs
Jak only for those who fail/can't teolrate anti TNF mab
Treatment of moderate to severe ACTIVE UC (top down therapy?) What agents high and low??? FOR PRIOR ANTI TNF MAB FAILURE/intolerance
Part of top down therapy (Early use of biologics/immune modulators)
Choose high or intermediate which are:
HIgh: tofacitinib, upadacitinib (JAKs), usektinumab
intermediate: mirki, riska, gusel
Low; adali, vedoli, ozamimod and etrasmiod
JAK i have higher risk of CV AEs and cancer than anti TNF in older adults, limited safety for JAK and S1p in pregnancy
Can use inflix or goli as last resort for top down therapy
Combo therapy for moderate to severe active UC how? Desslcate how?
If doing mono: Thiopurine/TMX NOT GOOD FOR MONO, but can use mono thiopurine to MAINTAIN remission for cortico induced
Combo with anti TNF: combo of modulator+biologic is preferred over monotherapy (but no evidence for combo with non anti TNF mab over non anti TNF mab monotherapy)
Stop 5 ASA once patient escalates to this combo
After 6 months of cortico free remission, DO NOT STOP ANTI MAB, and do not stop immuen modulator either
Severe-fulminant UC how treat for induction? (Severe vs fulminant diff) think ster
SEvere: preferred is budesonide or prednisone to remission
If don't respond, then can do IV methylprednisolone ir Hcortisone IV until stable and then switch to oral corticosteroid
Add azt, 6mp, inflix, certoli, adali, vedoli or tofacitinib and attempt steroid taper after 1-2 months (cause no 8 weeks
For fulminant: If don't respond, then can do IV methylprednisolone ir Hcortisone IV until stable and then switch to oral corticosteroid
If no response after 3-5 days, infliximab or cyclosporine Iv to remission
Maintenance for severe-fulminant UC?
Severe: AZt, 6mp or anti tnf mab (Mono)
Fulminant: Continue inflixi, vedozilu, or contineu oral cyclosporine with azt or 6mp
UC prognosis: goal and risk factor how?
Sustain steroid free remission
Most have mildly active disease that cna be managed with long term mesalamine
Left ove are risk of steroid depndence, surgery (and even with surgery can still come back)
UC is risk factor for colon cancer
how treat mild CD with low risk of progression? (limited to ileum and colon) induction vs maintenance)
Induction: Budesonide Enteric coated for 4-8 weeks preferred: if no response then switch
Maintenance: No relapse on budesonide, follow up colonoscopy at 6-12 months
If relapse on budesonide taper, then restart budesonide (with taper over 3 months)+ immune modulator
how treat mild CD with low risk of progression? (Diffuse/Distal colonic involved) induction vs maintenance)
Induction: PREDNISONE for 1 week PO, then taper over 1-2 months, if no response at 1 week then switch
maintain: no relapse on prednisone taper then monitor and follow up with colonoscopy at 6-12 months
If relapse, restart and add immune modulator
How treat moderate to severe active CD with moderate-high risk of progression (Induction) (if have fistula vs no fistula and alts) (Monotherapy when?)
If have perianal/intestinal fistula present: Then anti TNF mAb+immunomodulator (AZT preferred) (can use MTX as sub if patient can't take thiopurine OR HAS ARTHRITIS
Vedolizumab monotherapy for >60 yo or hx of cancer or infections
No fistulas then: anti TNF mab+AZT or vedolizumab monotherapy (COrticosteroid for more rapid symptomatic relief)
Usetiknu mono for biologic naive patients
if failed before can do Ustekinumab+azt or MTX
Riskanizumab nonotherapy good now also lol
How treat moderate to severe active CD with moderate-high risk of progression (maintenance)
If patient achieved remission on anti TNF mAb+ immunomodulator, then cont combo for 1-2 years , then try to stop immunomodulator based on evaluation of activity
Most high irsk patients need lifelong maintenae though
If relpase on anti TNF mAb maintenance: test for neutralizing antibodies and trough level
Thiopurine mono can be used in those who got remission on corticosteroid or relpased on biologic
Induction therapy for hospitalized patients with severe to fulminant CD how? (1 drug and 1 consider) similar
IV methylprednisolone is FIRST LINE
ANti TNF a can be considered (most is with infliximab)
Treatment of perianal or fistulizing CD (what is 1st line?) 2 alts/add ons
Anti TNF a are 1st line for perianal (not so much for fistulas), is mostly infliximab or comb of infliximab+metronidazole
Thiopurine for perianal or fistulas
METRONIDAZOLE FOR PERIANAL FISTULAS
Prevent CD recurrence in post surgery how? (No risk factor, vs normal, vs good alt?) high risk what?
Mesalamine maybe if have isolated ileal resection with no risk factor for progression
Metronidazole otherwise for small intestine resection
Thiopurine effective at preventing clinical recurrence, but can't stop severe endoscopic recurrence
In high risk patients: anti TNF a should be started within 4 weeks of surgery (add immunodulator maybe)
CD Prognosis and 2 bad drugs for CD
Highest activity during first year after CD diagnosis
Without immunomodulator/biologic agent: Most patients become steroid dependent/refractory YIKES
Up to 80% of patients need hospitalization,
10 year risk of surgery is 40-55% (low as 30 with biologics)
5 year rate is 50%
10 year risk of 2nd surgery is 30-35%
NSAIDS and smoking can increase disease activity
Stress can also and decrease qol and adherence.
Liver store what and excrete what and protect how
Glycogen, ADEK and B12 vitammins, iron, copper.
Excrete Bile, IGF-1, blood proteins, cholesterol, fatty acids, makes coagulation factors too.
Purify, transform and clear stuff
Kupffer cells are residential macrophage.
Collects portal blood from GI tract

Acute vs Chronic Hepatitis
Occurs at different degrees.
Cell injury is less in acute phase, but biggest difference is FIBROSIS
CHronic, you ALWAYS SEE FIBROSIS
Acute just have normal inflammatory infiltrate and macrophage.
Nomenclature for liver disease
Is now MASLD (used to be nonalcoholic fatty liver disease)
Have Alcohols use disroder and related liver diseases
(used to be alcoholic fatty lvier disease)
ASH and MASH descriptions (what have)
A:Alcoholic, MA: Metabolic dysfunction associated steatohepatitis
Both have fat, macro vesicular steatosis: big lipid droplets filling up liver.
Also have micro steatosis(initial response to damage)
Also have inflammation for sure, like Kupffer cells, T cells, NK cells, etc.
MASH: Lots of big white cells (Lipid droplets), can be irregular shape which is glycogen. Blue dots=inflammatory infiltrates.
Also have Mallory-Denk bodies: Are like cores of protein aggregates that can't be destroyed. Also have chicken wire fibrosis
MASH characteristics 6 (bigger how? deaths and stuff, and conditino of patient?)
Form of NAFLD
Steatosis, lobular inflammation, hepatocyte ballooning (accommodate death and growth), fibrosis (mainly chronic), metabolic syndrome
MASH Prevlanece in US
30-40% of population has simple steatosis, fatty liver disease is most common cause of abnormal liver tests.
20% of patients have MASH, and a little of cancer.
Liver lipid homeostasis
If eat a lot of simple carb, and liver breaks down the acetyl COA into FFA, and incorporate into VLDL out of liver. IF not excreted out of liver, have lipid accumlation.
If eat a lot of fat, fat from adipocyte will release into circulation and then taken up by blood and also cause lipid accumulation.
If lipid not excreted readily get fatty liver that way.
If no food eaten, get ADP, no oxidation and ketone body formation can occur. So can have lean fatty liver disease, dysfunction of mitochondria.
If have decreased beta oxidation and lipid transport, then ggs.
Two hit theory:
First hit: fat accumulate in liver (obesity/long term fasting)
second hit: injury leads to inflammation (Drugs, pathogens, leaky gut, genetic oofs, oxidative stress)
Alcoholism and alcohol use disorder
Basically get addicted to it, have binge drinking and all that.
Seeking that alc.
Seeking alcohol and binge drinking.
ASH Pathophysiology (lots of damage 3 things)
Similar to fatty liver with hepatic fat storage but also have:
Inflammation: increased hepatic uptake of gut derived endotoxins (like fungi, that stuff trigger liver first) trigger Kupffer cell activation and release factors
Oxidation: Induce CYp2E1 make toxic acetaldehyde and ROS
ER Stress: Ethanol mediated ER stress, cause protein mis folding.
Alcohol increased fatty acid synthesis and less oxidation, and activate innate immunity
Liver Fibrosis how? bad?
Persistent HSC activation, fibrosis is potentially irreversible.
Keeping on producing those fibrinous materials around cells with chronic inflammation: good at first since it seals and walls off damaged area to localize repair, but too long and too much is bad.
Eventually lower hepatic blood flow, numerous seequelae
And eventually need lvier transplantation
Cirrhosis induced by MASH
Some just stay in fibrotic state, never go into cirrhosis, but get early carcinoma. REALLY DANGEROus cause hard to diagnose those people
NASH features may not be seen like balloon and stuff, but fibrosis is still there
Algo for diagnosing steatosis liver disease
Check metabolic syndrome (BP>130/85, TG>1.7, HDL
Then calculate FIB4 index for fibrosis (liver function+platelet count/smth).
Then check how much alcohol take:
If not much is MASLD
More than metALD: (both alcohol+metab)
if A lot: Straight ALD
If none with no risk factors is MASLD or cryptogenic
How treat MASH/ASH-1
Reduce weight through exercise and diets (Japanese)
Treat T2DM
Reduce/do not drink ETOH
Avoid drugs/toxins with liver injury (DONT DRINK WHILE SICK)
Avoid pathogens/drugs with gut injury
Resmetirom MOA DDIs??
Ligand of thyroid hormone receptor beta, is a prodrug metabolized in liver
Improve hepatic conversino of T4 to T3 and help mticohondrial function
THRB is in liver, kidneys, pit gland and brain
Avoid alpha receptor since cause heart and bone ADEs (receptor in heart)
OATPB1 substrate so DDI with statins
Have some GI effect. Not a perfect drug.
Used for MASH/ASH-2
Semaglutide and MASH w/ fibrosis
Approved in 2025, and GI and GS side effects.
Now indicated for MASH
Reduce inflammation and stuff nice.
How prevent cirrhosis in patients with MASH, 2 drug classes and HOW FOLLOW UP FOR SURGERY
Lose weight and exercise and diet. (restrict sodium to stop volume overload)
Use GLP-1s in stage F2-F3 fibrosis (semaglutide has actual indication, others are off label: want to lose 7-10% of body weight)
Resmetirom: Can use if reach F2-F3 and failed GLP-1 therapy
Can also do bariatric surgery, but can have worsening of fibrosis, gotta monitor closely:
Monitor liver at 6 weeks, 3 months and 6 months; if have compensated cirrhosis follow up at 1 and 3 months.
Semaglutide good how, dangers/AEs (Cancer, pan, k, t2, brain)
Dis? (hypo and oral drugs)
Improve metavir fibrosis staging
Risk of thyroid C cell tumors, acute pancreatitis, AKI 2nd to volume depletion, diabetic retinopathy in t2DM, suicidal behavior/ideation. CLASS WARNING
DI with insulin and sulfonyulrea
Delay GI emptying time, so rip absorption
Resmetirom ADEs and DIs? (What cyp)
Liver tox, gallbladders
AVOID USE WITH MDOERATE-STRONG CYp2C8 INHIBITOR (Gemfibrozil, clopidogrel)
2nd line to GLP-1s
What wanna get from fluid/paracentesis
Want cell count/WBC, Albumin, Protein, culture negative
and also check Sodium conc from urine.
Cirrhosis lab values HVPG, and how diagnose decompensated? (2 big, 1 increased risk)
Defined by portal hypertension, so have ascites/volume overload, variceal bleeidng, hepatic encephalopathy
3-5 is normal
>5-10 is portal HTN
BUt >10-12 is CLINICALLY SIGNIFICANT HTN (is compensated cirrhosis): can have varices, risk of progression to HCC and decompensation
>12: decompensated esp, (Decompensated ONLY IF HAVE ONE OF THE 3 ISSUES):
Formation of ascites: most common presentation
increased risk of variceal bleeding
hepatic encephalopathy
Staging of cirrhosis 4 ways
Metavir score: same f1-F4
Child Pugh score
Fib4 (1.3 ok, 1.3-2.67 intermedaite risk, >2.67. high risk)
Presentations of cirrhosis symptoms?
OFten asymptomatic until decompensation occurs
Have nonspecific like anorexic, fatigue, GI
Jaundice, hepatosplenomegaly
Gynecomastia, testicular atrophy, spider nevi, palmar eryhthema
astirexis
Labs of cirrhosis?
Low BUn and ALbumin, low blood, prolonged INR (normal is 0.8-1.1), increased ammonia (usual is 10-32, comes from breaking down protein, want to reduce pH so have more ionized ammonia so it can be absorbed)
Liver enzymes
3 ways to diagnose cirrhosis
Imaging
Biopsy
Noninvasive methods: Pugh score, meld score
Cirrhosis specific complications how treat (Decomp, vari, ence, read, HCC)
CARVEIDOLOL FOR HEPATIC DECOMPESNATION,
Carvedilol for variceal complication or IV ABX
Lactose for hepatic encephalopathy (+/- rifaximin)
Hospital readmission: Multi modal discharge interventions
HCC: Check, NO ASPIRIN
Non liver specific complications (Osteo, cancer), infection prevention an dlifestyle factors?
Osteo: Screen dexa, bisphopshonates
Screen for cancer, and make sure they vaccinated
Exercise, good nutrition, NO ALCOHOL, stop smoking
Cirrhosis management
Only definitive treatment is liver transplant, everything else is supportive
Treat underlying cause, and manage complications
BP SUPPPORT: If MAP
MELD Score
Accoutns for gender, biliburin, Na, Albumin, INR, Creatinine
If have 30-40: SIckest patients, high prio for liver transplant
if 25-40 recheck every 7 days HIGH CHDNACE OF DEATH
if 19-24, recheck in 1 month
11-18 q 3 months 6% chance of death in 90 days
6-10 q 1 year, mild
Stage 1-5 for MELD
1: compensated cirrhosis no varices
2: Compensated with varices
3: Decompensated with ascites
4: Decompensated cirrhosis with IG Bleed
5: Infection/hepatorenal snydrome/renal failure
Ascites presentation and symptoms
Can also have hepatic hydrothorax where fluid leaks into pleural cavity, not peritoneal like asites.
Ab distention with firm abdomen shifting on palpation
Increase ab rith and 15 lb weight gain according to patient HX
5L of fliud removed by parancentesis, ingest 88mEq Na but only excreting 50
Ascites MOA
Increased portal venous pressure and decreased plasma oncotic pressure (albumin determine this)
IV volume depletion and decreased renal perfusoin leads to increased plasma renin activity (retention)
Use non selective beta blocker if HVPG Is high TO PREVENT ascites, not treat
How manage ascites (alc, Na how much, what drug x2)
What drugs to avoid?
ALCOHOL ABSITENENCE
Sodium restriction (88mEq/day)
Diuretics: Combo of spironolactone+Furosemide
NO NONSELECTIVE BETA BLOCKER esp for advanced cirrhosis where MAP going down
ACEi ARB (rip kidneys)
NO NSAIDS
or nephrotoxicd rugs
Protect kidney